Marketing spend at scale is capital deployment
Every dollar of media spend in a large multi-site portfolio is capital deployed with an expected return. When that capital is allocated based on geography, location count, or historical precedent rather than demonstrated return on investment, the inevitable result is a portfolio where some markets produce exceptional CAC (Customer Acquisition Cost) efficiency while others absorb capital at low or negative returns.
Most platforms discover this pattern not through analysis but through accumulation — years of roughly equal budget distribution that made sense at 10 locations but is producing wildly unequal returns at 100. The markets that are underperforming are not always obvious from the campaign dashboard because the spend is running and impressions are being delivered. The problem is only visible when location-level CAC is calculated and mapped against production outcomes. That analysis is where portfolio-level capital management starts.
What a portfolio-level CAC dashboard actually shows you
A portfolio-level CAC management dashboard displays patient acquisition cost by location, by market cluster, and by channel — with trend lines over time and benchmarks across the portfolio. Building it requires integrating media spend data, location-level attribution, and production revenue into a single view. The integration work is real. So is what the dashboard reveals when it’s finally in place.
The first finding is almost always a distribution that surprises platform leadership: the top-quartile locations are acquiring patients at two to three times the efficiency of the bottom quartile, often in markets that look demographically similar on the surface. The second finding is usually a channel that is consuming a disproportionate share of the portfolio budget while delivering a disproportionately small share of efficient acquisitions — a pattern invisible in location-level reporting because each location’s spend on that channel looks reasonable in isolation. Seeing the portfolio simultaneously is what reveals the pattern. That’s the management value of the dashboard: it turns portfolio-level decisions from intuition into data.
Structural vs. executional inefficiency: Why the distinction changes the response
The most valuable insight from a portfolio-level CAC analysis is the identification of markets that are consistently efficient and markets that are consistently inefficient. But efficient and inefficient markets require different management responses — and before you can choose the right one, you need to understand why a market is underperforming.
Structural inefficiency is rooted in market conditions: high competitive density that drives up paid search CPCs, demographic profiles that don’t align well with the platform’s service mix, or payer mix characteristics that limit the pool of profitable patients regardless of marketing investment. These markets don’t respond to better campaigns. They respond to reduced investment and redirected capital. Executional inefficiency looks different: the market has strong demographic potential and reasonable competitive density, but CAC is high because of poor targeting, weak conversion infrastructure, or underweighted channels. These markets respond to better campaigns — and the reallocation decision is to invest more, not less, while fixing what’s broken. Confusing one for the other is an expensive mistake. Structural markets reward patience and capital discipline. Executional markets reward intervention.
Which channels hold at scale – and which don’t
Not every media channel performs consistently across a large multi-site healthcare portfolio, and the channels that degrade fastest at scale are not always the ones that seem most at risk. In multi-site healthcare, paid search tends to hold its efficiency longer than paid social as the portfolio expands — because search intent is demand the patient already has, while social is demand the platform is creating. As location footprints overlap and social audiences become saturated, frequency rises, and CPMs climb without a corresponding increase in appointment volume. The performance looks stable in location-level dashboards because each location’s campaign appears to be running normally. The degradation is only visible at the portfolio level.
Channel efficiency modeling — analyzing cost per profitable patient by channel and market rather than by campaign — surfaces which media channels are maintaining returns at scale and which are consuming an increasing share of budget for a decreasing share of output. In most large multi-site portfolios, this analysis reveals one or two channels that are systematically overweighted relative to their efficient patient acquisition output, and one or two that are underweighted because their CPL looks high even though their cost per profitable patient is low. Rebalancing on the latter metric, rather than the former, is what moves blended portfolio CAC.
What budget reallocation looks like in practice
Once location-level and channel-level CAC data exists, budget reallocation becomes a direct EBITDA lever — not a media planning exercise. The mechanics are straightforward: identify the markets and channels producing the highest cost per profitable patient, establish a threshold below which continued investment is not justified by expected return, and redirect that budget to the markets and channels where efficiency is high and the acquisition opportunity is not yet saturated.
In practice, meaningful reallocation typically involves moving 15 to 25 percent of the total portfolio budget — not a wholesale rebuild of the media plan, but a deliberate concentration of investment toward demonstrated efficiency. The analysis that drives it should run quarterly, because market efficiency shifts as competitive dynamics, demographics, and platform footprint change. A market that was efficient 18 months ago may have saturated. A market that was inefficient because of weak infrastructure may now be a high-efficiency opportunity after the attribution build was completed. Portfolio CAC management is not a one-time exercise. It is a quarterly capital allocation review with a financial model behind it.
Why CAC improvement compounds – and what to do with the freed capital
A 15 percent reduction in blended portfolio CAC across a 100-location platform is not a marketing efficiency win. It is a capital event. At a $10 million annual marketing budget, 15 percent is $1.5 million in annual spend that was previously producing below-threshold returns, now available for redeployment. The EBITDA impact of that redeployment depends on what happens next — and this is the decision point where the capital allocation framing matters most.
The freed capital has three meaningful uses, each with different implications for platform value. Reinvesting it in high-efficiency markets that are currently underfunded relative to their acquisition opportunity compounds the efficiency gain — more capital at lower CAC produces more profitable patients at a higher margin. Reinvesting it in attribution infrastructure that further improves measurement precision sets up the next round of reallocation and makes future efficiency gains more achievable. Returning it to operating partners as margin improvement is the most direct path to EBITDA expansion and the use case that most clearly demonstrates marketing’s role as a capital management function rather than a cost center.
CMOs who can show consistent CAC improvement over time are demonstrating something sponsors value more than a strong quarter: a trend line that makes future performance predictable. Predictable CAC improvement is one of the most compelling marketing stories available in a PE-backed environment — because it connects directly to the valuation conversation that is always running in the background.
“A 15 percent reduction in blended portfolio CAC is not a marketing win. At a $10 million budget, it is $1.5 million in annual capital available for redeployment — and that is an EBITDA conversation.”
Agency Creative builds the portfolio-level CAC management infrastructure — the dashboard, the attribution foundation, and the quarterly reallocation framework — that makes systematic patient acquisition improvement possible at scale. Let’s look at where your portfolio efficiency stands today.
Learn how Agency Creative can help boost your brand by calling us at 972.488.1660 or by contacting us online.
See More Work
